ZKY 006
Alternative Names: ZKY-006Latest Information Update: 28 Jan 2024
At a glance
- Originator China Ophthalmology Focus
- Developer Zhaoke Ophthalmology Limited
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Eye disorders
Most Recent Events
- 28 Jan 2024 No recent reports of development identified for phase-I development in Eye-disorders in China (Ophthalmic)
- 10 Dec 2020 Phase-I clinical trials in Eye disorders in China (Ophthalmic) before December 2020 (Lee's Pharmaceutical pipeline, December 2020)